Celmatix
A preclinical-stage women’s health biotech focused uniquely on ovarian biology.
New York, United States
24 employees
Venture round
Total: $53.66M
Biotechnology, Health Care +1
General Information
New York, United States
BounceWatch is an independent company data service, not affiliated with Celmatix. To contact Celmatix, visit celmatix.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
Discover More
United States Market
Biotechnology
About Celmatix
Taxonomy: Biotech, Women's Health, Reproductive Health, Fertility, Ovarian Biology, Drug Development, Genomics, Bioinformatics, Preclinical-Stage Biotech, Ovarian Senescence, Non-Hormonal Contraception, Pipeline-in-a-pill, AMHR2 Program, Collaborations, Multi-Omic Ovarian Health Platform
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $6.50M | 3 |
|
01 Apr 2019 |
| Venture Round | $21.00M | - |
|
01 Feb 2017 |
| Venture Round | $6.70M | - |
|
18 Mar 2016 |
| Venture Round | $5.90M | - |
|
08 Sep 2015 |
| Venture Round | $5.51M | - |
|
03 Dec 2014 |
| Venture Round | $1.50M | - |
|
01 Jun 2014 |
| Venture Round | $4.00M | - |
|
15 Feb 2013 |
| Series A | $1.75M | 4 |
|
03 Mar 2012 |
| Series A | $550.00K | 1 |
|
25 Feb 2011 |
| Angel Round | $250.00K | 1 |
|
01 Jan 2010 |
Celmatix Alternatives & Competitors
View All Alternatives
Better drugs, faster. For patients who can’t wait.
We revolutionize women's quality of life and freedom of choice with healthier, safer uterine drug-de...
Advancing Antisense Therapeutics: Preclinical-stage ASO developer leveraging proprietary XNAs & Luxi...
FAQ About Celmatix
Source: BounceWatch company record for Celmatix, https://bouncewatch.com/company/celmatix, updated 30 December 2024. When citing, please name BounceWatch and link this page.
